CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
paclitaxel coated balloon catheter (device with drug)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00409981
NCT00409981Phase 2Completed

Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II)

University Hospital, Saarland·interventional·Posted Dec 12, 2006·Updated Dec 12, 2006

In Brief

A Phase 2 clinical trial evaluating paclitaxel coated balloon catheter (device with drug) for Coronary Restenosis. Completed, across 5 sites.

Detailed Summary

The PACCOCATH ISR II study is a randomized, double-blinded German multicenter trial on the efficacy and tolerance of a paclitaxel coated balloon catheter in coronary in-stent restenosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 12, 2006
Enrollment StartJul 1, 2004
Study CompletionJun 1, 2006
TodayJul 2, 2026
Posted 19.6 years ago

Interventions

paclitaxel coated balloon catheter (device with drug)device